Search

Displaying results 4071 - 4080 of 5449 in total
  1. Drug

    OTOF-GT

    go.drugbank.com/drugs/DB18129
    Investigational

    OTOF-GT is a dual vector AAV gene therapy being investigated for the restoration of hearing loss associated with otoferlin deficiency.

  2. Drug

    TTX-MC138

    go.drugbank.com/drugs/DB18628
    Investigational

    [L48335] It is under investigation for the treatment of various metastatic cancers.

  3. Drug

    Efineptakin alfa

    go.drugbank.com/drugs/DB16395
    Investigational

    Efineptakin alfa (also known as NT-I7) is a long-acting human interleukin-7 (IL-7) fusion protein that promotes T-cell development, contributing to the immune response. … Compared to endogenous IL-7, NT-I7 is more stable and potent, has a longer half-life, and has better bioavailability.

    Synonyms: NT-I7
  4. Drug

    Benzododecinium

    go.drugbank.com/drugs/DB13282
    Investigational

    It has been marketed as a tincture for antiseptic product for wounds in the Czech Republic.

  5. Drug

    Idronoxil

    go.drugbank.com/drugs/DB04915
    Investigational

    It belongs to the family of drugs called signal transduction inhibitors.

    Synonyms: Haginin E
  6. Drug

    BQ-123

    go.drugbank.com/drugs/DB12054
    Investigational

    BQ-123 has been investigated for the basic science and treatment of Coronary Artery Disease, Aorto-coronary Bypass Grafting, and ST-Elevation Myocardial Infarction.

  7. Drug

    Salix alba bark volatile oil

    go.drugbank.com/drugs/DB14354
    Investigational

    It is not an approved drug.

  8. Drug

    PR006

    go.drugbank.com/drugs/DB17002
    Experimental

    It is being investigated for the treatment of dementia.

  9. Drug

    MOD-5014

    go.drugbank.com/drugs/DB17715
    Investigational

    [A259088] It is being investigated for the treatment of hemophilia.[L46173]

  10. Drug

    QS-21

    go.drugbank.com/drugs/DB05400
    Investigational

    It is the leading member of the Stimulon family of adjuvants. As a vaccine additive, it is currently being evaluated in clinical trials in a variety of disease areas by Antigenics.